BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 12843684)

  • 1. Reduction of infarct size by short-term pretreatment with atorvastatin.
    Birnbaum Y; Ashitkov T; Uretsky BF; Ballinger S; Motamedi M
    Cardiovasc Drugs Ther; 2003 Jan; 17(1):25-30. PubMed ID: 12843684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspirin before reperfusion blunts the infarct size limiting effect of atorvastatin.
    Birnbaum Y; Lin Y; Ye Y; Martinez JD; Huang MH; Lui CY; Perez-Polo JR; Uretsky BF
    Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H2891-7. PubMed ID: 17277020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atorvastatin, administered at the onset of reperfusion, and independent of lipid lowering, protects the myocardium by up-regulating a pro-survival pathway.
    Bell RM; Yellon DM
    J Am Coll Cardiol; 2003 Feb; 41(3):508-15. PubMed ID: 12575984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simvastatin-induced myocardial protection against ischemia-reperfusion injury is mediated by activation of ATP-sensitive K+ channels.
    Tavackoli S; Ashitkov T; Hu ZY; Motamedi M; Uretsky BF; Birnbaum Y
    Coron Artery Dis; 2004 Feb; 15(1):53-8. PubMed ID: 15201621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostaglandins mediate the cardioprotective effects of atorvastatin against ischemia-reperfusion injury.
    Birnbaum Y; Ye Y; Rosanio S; Tavackoli S; Hu ZY; Schwarz ER; Uretsky BF
    Cardiovasc Res; 2005 Feb; 65(2):345-55. PubMed ID: 15639473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation cardioprotective effects of atorvastatin in rats by real time myocardial contrast echocardiography.
    Filusch A; Buss S; Hardt S; Katus HA; Kuecherer HF; Hansen A
    Echocardiography; 2008 Oct; 25(9):974-81. PubMed ID: 18771549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of atorvastatin on expression of IL-10 and TNF-alpha mRNA in myocardial ischemia-reperfusion injury in rats.
    Sun YM; Tian Y; Li X; Liu YY; Wang LF; Li J; Li ZQ; Pan W
    Biochem Biophys Res Commun; 2009 May; 382(2):336-40. PubMed ID: 19275881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pretreatment with high-dose statin, but not low-dose statin, ezetimibe, or the combination of low-dose statin and ezetimibe, limits infarct size in the rat.
    Birnbaum Y; Lin Y; Ye Y; Merla R; Perez-Polo JR; Uretsky BF
    J Cardiovasc Pharmacol Ther; 2008 Mar; 13(1):72-9. PubMed ID: 18287593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced cardioprotection against ischemia-reperfusion injury with combining sildenafil with low-dose atorvastatin.
    Rosanio S; Ye Y; Atar S; Rahman AM; Freeberg SY; Huang MH; Uretsky BF; Birnbaum Y
    Cardiovasc Drugs Ther; 2006 Feb; 20(1):27-36. PubMed ID: 16435070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of myocardial infarct size by fluvastatin.
    Tiefenbacher CP; Kapitza J; Dietz V; Lee CH; Niroomand F
    Am J Physiol Heart Circ Physiol; 2003 Jul; 285(1):H59-64. PubMed ID: 12623790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Failure to protect the myocardium against ischemia/reperfusion injury after chronic atorvastatin treatment is recaptured by acute atorvastatin treatment: a potential role for phosphatase and tensin homolog deleted on chromosome ten?
    Mensah K; Mocanu MM; Yellon DM
    J Am Coll Cardiol; 2005 Apr; 45(8):1287-91. PubMed ID: 15837263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early statin treatment prior to primary PCI for acute myocardial infarction: REPERATOR, a randomized placebo-controlled pilot trial.
    Post S; Post MC; van den Branden BJ; Eefting FD; Goumans MJ; Stella PR; van Es HW; Wildbergh TX; Rensing BJ; Doevendans PA
    Catheter Cardiovasc Interv; 2012 Nov; 80(5):756-65. PubMed ID: 22419603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of endothelial nitric oxide synthase and vagal activity in the endothelial protection of atorvastatin in ischemia/reperfusion injury.
    Bi XY; He X; Zhao M; Yu XJ; Zang WJ
    J Cardiovasc Pharmacol; 2013 May; 61(5):391-400. PubMed ID: 23364605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rosuvastatin reduces experimental left ventricular infarct size after ischemia-reperfusion injury but not total coronary occlusion.
    Weinberg EO; Scherrer-Crosbie M; Picard MH; Nasseri BA; MacGillivray C; Gannon J; Lian Q; Bloch KD; Lee RT
    Am J Physiol Heart Circ Physiol; 2005 Apr; 288(4):H1802-9. PubMed ID: 15563531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cardioprotective effect of a statin and cilostazol combination: relationship to Akt and endothelial nitric oxide synthase activation.
    Manickavasagam S; Ye Y; Lin Y; Perez-Polo RJ; Huang MH; Lui CY; Hughes MG; McAdoo DJ; Uretsky BF; Birnbaum Y
    Cardiovasc Drugs Ther; 2007 Oct; 21(5):321-30. PubMed ID: 17620005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of acute and chronic atorvastatin on cardioprotection of ischemic postconditioning in isolated rat hearts.
    Fan Y; Yang S; Cao Y; Huang Y
    Cardiovasc Ther; 2013 Aug; 31(4):187-92. PubMed ID: 22954178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caffeinated coffee blunts the myocardial protective effects of statins against ischemia-reperfusion injury in the rat.
    Ye Y; Abu Said GH; Lin Y; Manickavasagam S; Hughes MG; McAdoo DJ; Perez-Polo RJ; Birnbaum Y
    Cardiovasc Drugs Ther; 2008 Aug; 22(4):275-82. PubMed ID: 18327703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atorvastatin-induced cardioprotection is mediated by increasing inducible nitric oxide synthase and consequent S-nitrosylation of cyclooxygenase-2.
    Atar S; Ye Y; Lin Y; Freeberg SY; Nishi SP; Rosanio S; Huang MH; Uretsky BF; Perez-Polo JR; Birnbaum Y
    Am J Physiol Heart Circ Physiol; 2006 May; 290(5):H1960-8. PubMed ID: 16339820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of cerebral infarct size by the AT1-receptor blocker candesartan, the HMG-CoA reductase inhibitor rosuvastatin and their combination. An experimental study in rats.
    Engelhorn T; Doerfler A; Heusch G; Schulz R
    Neurosci Lett; 2006 Oct; 406(1-2):92-6. PubMed ID: 16901636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Edaravone reduces myocardial infarct size and improves cardiac function and remodelling in rabbits.
    Onogi H; Minatoguchi S; Chen XH; Bao N; Kobayashi H; Misao Y; Yasuda S; Yamaki T; Maruyama R; Uno Y; Arai M; Takemura G; Fujiwara H
    Clin Exp Pharmacol Physiol; 2006 Nov; 33(11):1035-41. PubMed ID: 17042911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.